Latest & greatest articles for mortality

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on mortality or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on mortality and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for mortality

1. Statin Use Is Associated with a Decreased Risk of Mortality among Patients with COVID-19 Full Text available with Trip Pro

Statin Use Is Associated with a Decreased Risk of Mortality among Patients with COVID-19 Statin Use Is Associated with a Decreased Risk of Mortality among Patients with COVID-19 - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 Information Show account info Close Account Logged in as: username Search: Search Save Email Send (...) options Format Share Permalink Copy Page navigation J Clin Med Actions . 2021 Apr 1;10(7):1450. doi: 10.3390/jcm10071450. Statin Use Is Associated with a Decreased Risk of Mortality among Patients with COVID-19 , , , , , Affiliations Expand Affiliations 1 Department of Healthcare Information and Management, School of Health Technology, Ming Chuan University, Taipei 333, Taiwan. 2 Department of Exercise and Health Promotion, College of Kinesiology and Health, Chinese Culture University, 55 Yangmingshan

2021 EvidenceUpdates

2. Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study Full Text available with Trip Pro

Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features (...) Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation J Clin Oncol Actions . 2021 Apr 29;JCO2003488. doi: 10.1200/JCO.20.03488. Online ahead of print. Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study , , , , , , , , , , , , , , , , , , , Affiliations Expand

2021 EvidenceUpdates

3. D2 dissection improves disease-specific survival in advanced gastric cancer patients: 15-year follow-up results of the Italian Gastric Cancer Study Group D1 versus D2 randomised controlled trial

and gastric cancer-related mortality. Methods: Between June 1998 and December 2006, eligible patients with gastric cancer who signed the informed consent were randomised at 5 centres to either D1 or D2 gastrectomy. Intraoperative randomisation was implemented centrally by phone call. Primary outcome was overall survival (OS); secondary end-points were disease-specific survival, postoperative morbidity and mortality. Analyses were by intention to treat. Strict quality control measures for surgery, lymph (...) collection. Keywords: D2 lymph node dissection; Disease Specific Survival; Gastric cancer; Gastric cancer related mortality; Lymphadenectomy; Survival; advanced gastric cancer. Copyright © 2021 Elsevier Ltd. All rights reserved. Conflict of interest statement Conflict of interest statement All authors declare that they have no conflicts of interest. Similar articles Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ. Songun I, et al. Lancet Oncol. 2010 May;11(5):439-49. doi: 10.1016/S1470-2045

2021 EvidenceUpdates

4. The Range of Cardiogenic Shock Survival by Clinical Stage: Data From the Critical Care Cardiology Trials Network Registry

The Range of Cardiogenic Shock Survival by Clinical Stage: Data From the Critical Care Cardiology Trials Network Registry The Range of Cardiogenic Shock Survival by Clinical Stage: Data From the Critical Care Cardiology Trials Network Registry - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 Information Show account info (...) displayed: Create RSS Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation Crit Care Med Actions . 2021 Apr 2. doi: 10.1097/CCM.0000000000004948. Online ahead of print. The Range of Cardiogenic Shock Survival by Clinical Stage: Data From the Critical Care Cardiology Trials Network Registry , , , , , , , , , , , , , , , , , , Affiliations Expand Affiliation 1 1 Peter Munk Cardiac Centre, University Health Network, Toronto, ON, Canada. 2

2021 EvidenceUpdates

5. Intraoperative irradiation for early breast cancer (ELIOT): long-term recurrence and survival outcomes from a single-centre, randomised, phase 3 equivalence trial

-4·0). At final follow-up on March 11, 2019, 193 (15%) women had died from any cause, with no difference between the two groups (98 deaths in the ELIOT group vs 95 in the WBI group; HR 1·03, 95% CI 0·77-1·36, p=0·85). In the ELIOT group, the overall survival rate was 96·8% (95% CI 95·1-97·9) at 5 years, 90·7% (88·2-92·7) at 10 years, and 83·4% (79·7-86·4) at 15 years; and in the WBI group, the overall survival rate was 96·8% (95·1-97·9) at 5 years, 92·7% (90·4-94·4) at 10 years, and 82·4% (78·5 (...) Intraoperative irradiation for early breast cancer (ELIOT): long-term recurrence and survival outcomes from a single-centre, randomised, phase 3 equivalence trial Intraoperative irradiation for early breast cancer (ELIOT): long-term recurrence and survival outcomes from a single-centre, randomised, phase 3 equivalence trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other

2021 EvidenceUpdates

6. The effect of tocilizumab on COVID-19 patient mortality: A systematic review and meta-analysis of randomized controlled trials Full Text available with Trip Pro

The effect of tocilizumab on COVID-19 patient mortality: A systematic review and meta-analysis of randomized controlled trials The effect of tocilizumab on COVID-19 patient mortality: A systematic review and meta-analysis of randomized controlled trials - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 Information Show (...) displayed: Create RSS Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation Int Immunopharmacol Actions . 2021 Mar 24;96:107602. doi: 10.1016/j.intimp.2021.107602. Online ahead of print. The effect of tocilizumab on COVID-19 patient mortality: A systematic review and meta-analysis of randomized controlled trials , , , , Affiliations Expand Affiliations 1 Department of Orthopedic, Chi Mei Medical Center, Tainan 71004, Taiwan. 2 Division of Urology

2021 EvidenceUpdates

7. Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection: The INTERCOVID Multinational Cohort Study Full Text available with Trip Pro

Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection: The INTERCOVID Multinational Cohort Study Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection: The INTERCOVID Multinational Cohort Study - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily (...) Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation JAMA Pediatr Actions . 2021 Apr 22;e211050. doi: 10.1001/jamapediatrics.2021.1050. Online ahead of print. Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection: The INTERCOVID Multinational Cohort Study

2021 EvidenceUpdates

8. Anticoagulation and In-Hospital Mortality From Coronavirus Disease 2019: A Systematic Review and Meta-Analysis Full Text available with Trip Pro

Anticoagulation and In-Hospital Mortality From Coronavirus Disease 2019: A Systematic Review and Meta-Analysis Anticoagulation and In-Hospital Mortality From Coronavirus Disease 2019: A Systematic Review and Meta-Analysis - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 Information Show account info Close Account Logged (...) Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation Meta-Analysis Clin Appl Thromb Hemost Actions . Jan-Dec 2021;27:10760296211008999. doi: 10.1177/10760296211008999. Anticoagulation and In-Hospital Mortality From Coronavirus Disease 2019: A Systematic Review and Meta-Analysis , , , , Affiliations Expand Affiliations 1 Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society

2021 EvidenceUpdates

9. Pretreatment With Mifepristone Compared With Misoprostol Alone for Delivery After Fetal Death Between 14 and 28 Weeks of Gestation: A Randomized Controlled Trial

Pretreatment With Mifepristone Compared With Misoprostol Alone for Delivery After Fetal Death Between 14 and 28 Weeks of Gestation: A Randomized Controlled Trial Pretreatment With Mifepristone Compared With Misoprostol Alone for Delivery After Fetal Death Between 14 and 28 Weeks of Gestation: A Randomized Controlled Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced (...) Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation Obstet Gynecol Actions . 2021 May 1;137(5):801-809. doi: 10.1097/AOG.0000000000004344. Pretreatment With Mifepristone Compared With Misoprostol Alone for Delivery After Fetal Death Between 14 and 28 Weeks of Gestation: A Randomized Controlled Trial , , , , , , , Affiliations Expand Affiliation 1 Division

2021 EvidenceUpdates

10. A risk score based on baseline risk factors for predicting mortality in COVID-19 patients Full Text available with Trip Pro

A risk score based on baseline risk factors for predicting mortality in COVID-19 patients A risk score based on baseline risk factors for predicting mortality in COVID-19 patients - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 Information Show account info Close Account Logged in as: username Search: Search Save Email (...) options Display options Format Share Permalink Copy Page navigation Curr Med Res Opin Actions . 2021 Apr 10;1-11. doi: 10.1080/03007995.2021.1904862. Online ahead of print. A risk score based on baseline risk factors for predicting mortality in COVID-19 patients , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Affiliations Expand Affiliations 1 Department of Cardiology, Renmin Hospital, School of Basic Medical Science, Wuhan University, Wuhan

2021 EvidenceUpdates

11. Tranexamic acid to reduce head injury death in people with traumatic brain injury: the CRASH-3 international RCT Full Text available with Trip Pro

Tranexamic acid to reduce head injury death in people with traumatic brain injury: the CRASH-3 international RCT Tranexamic acid to reduce head injury death in people with traumatic brain injury: the CRASH-3 international RCT Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website search above to find (...) the information you need. >> >> >> >> Issue {{metadata .Issue }} Toolkit 1)"> 0)"> 1)"> {{metadata.Title}} {{metadata.Headline}} Tranexamic acid was safe in patients with traumatic brain injury and treatment within 3 hours of injury reduced head injury-related death, with a cost/QALY of £4300 in those with mild or moderate head injury. {{author}} {{($index , , , , , , , , , , , , , , , , , , & . Ian Roberts 1, * , Haleema Shakur-Still 1 , Amy Aeron-Thomas 2 , Danielle Beaumont 1 , Antonio Belli 3 , Amy

2021 NIHR HTA programme

12. Clinical Features of the 60 Years and Older Patients Infected with 2019 Novel Coronavirus: Can We Predict Mortality Earlier?

Clinical Features of the 60 Years and Older Patients Infected with 2019 Novel Coronavirus: Can We Predict Mortality Earlier? Clinical Features of the 60 Years and Older Patients Infected with 2019 Novel Coronavirus: Can We Predict Mortality Earlier? - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 Information Show account (...) displayed: Create RSS Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation Gerontology Actions . 2021 Mar 30;1-8. doi: 10.1159/000514481. Online ahead of print. Clinical Features of the 60 Years and Older Patients Infected with 2019 Novel Coronavirus: Can We Predict Mortality Earlier? , , , , , Affiliations Expand Affiliations 1 Department of Emergency Medicine, Haydarpasa Numune Training and Research Hospital, University of Health Sciences

2021 EvidenceUpdates

13. Adrenaline to improve survival in out-of-hospital cardiac arrest: the PARAMEDIC2 RCT Full Text available with Trip Pro

Adrenaline to improve survival in out-of-hospital cardiac arrest: the PARAMEDIC2 RCT Adrenaline to improve survival in out-of-hospital cardiac arrest: the PARAMEDIC2 RCT Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website search above to find the information you need. >> >> >> >> Issue {{metadata .Issue (...) }} Toolkit 1)"> 0)"> 1)"> {{metadata.Title}} {{metadata.Headline}} This trial found that 3.2% of people treated with adrenaline following out-of-hospital cardiac arrest survived to 30 days, compared with 2.4% of people receiving placebo. {{author}} {{($index , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , & . Gavin D Perkins 1, 2, * , Chen Ji 1 , Felix Achana 1 , John JM Black 3 , Karl Charlton 4 , James Crawford 1 , Adam de Paeztron 1 , Charles Deakin 5 , Mark Docherty 6 , Judith Finn 7

2021 NIHR HTA programme

14. Predicting readmission and death after hospital discharge: a comparison of conventional frailty measurement with an electronic health record-based score

of discharge. Methods: patients underwent Fried, Short Physical Performance Battery (SPPB), PRISMA-7 and Clinical Frailty Scale (CFS) assessments. An EHR risk score was derived from the proportion of 31 possible frailty markers present. Electronic follow-up was completed for a primary outcome of 90-day readmission or death. Secondary outcomes were mortality and days alive at home ('home time') at 12 months. Results: in total, 186 patients were included (79 ± 6 years old, 64% males). The primary outcome (...) Predicting readmission and death after hospital discharge: a comparison of conventional frailty measurement with an electronic health record-based score Predicting readmission and death after hospital discharge: a comparison of conventional frailty measurement with an electronic health record-based score - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features

2021 EvidenceUpdates

15. Bridging the age gap in breast cancer: cluster randomized trial of the effects of two decision support interventions for older women with operable breast cancer on quality of life, survival, decision quality, and treatment choices Full Text available with Trip Pro

Bridging the age gap in breast cancer: cluster randomized trial of the effects of two decision support interventions for older women with operable breast cancer on quality of life, survival, decision quality, and treatment choices Bridging the age gap in breast cancer: cluster randomized trial of the effects of two decision support interventions for older women with operable breast cancer on quality of life, survival, decision quality, and treatment choices - PubMed This site needs JavaScript (...) of the effects of two decision support interventions for older women with operable breast cancer on quality of life, survival, decision quality, and treatment choices , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Affiliations Expand Affiliations 1 Department of Oncology and Metabolism, University of Sheffield Medical School, Sheffield, UK. 2 Brighton and Sussex Medical School, Falmer, Brighton, UK. 3 College of Health, Wellbeing and Life Sciences, Department of Allied Health

2021 EvidenceUpdates

16. Nomogram for prediction of fatal outcome in patients with severe COVID-19: a multicenter study Full Text available with Trip Pro

independent high-risk factors associated with fatal outcome. We developed the nomogram for identifying survival of severe COVID-19 patients in the training cohort (AUC = 0.900, 95% CI 0.841-0.960, sensitivity 95.5%, specificity 77.5%); in validation cohort 1 (AUC = 0.811, 95% CI 0.763-0.961, sensitivity 77.3%, specificity 73.5%); in validation cohort 2 (AUC = 0.862, 95% CI 0.698-0.924, sensitivity 92.9%, specificity 64.5%). The calibration curve for probability of death indicated a good consistence (...) , and to develop more appropriate treatment strategies to reduce the mortality of severe patients. Tocilizumab may improve the prognosis of severe COVID-19 patients with high levels of IL-6. Keywords: Nomogram; Prediction; Severe COVID-19; Survival. Conflict of interest statement The authors declare that they have no competing interests. Figures Fig. 1 Risk prediction nomogram for patients… Fig. 1 Risk prediction nomogram for patients with COVID-19 Fig. 1 Risk prediction nomogram for patients with COVID-19 Fig

2021 EvidenceUpdates

17. Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England Full Text available with Trip Pro

diabetes and registered with a general practice in England since 2003. Cox regression was used to estimate the hazard ratio (HR) of COVID-19-related mortality in people prescribed each class of glucose-lowering drug, with covariate adjustment with a propensity score to address confounding by demographic, socioeconomic, and clinical factors. Findings: Among the 2 851 465 people with type 2 diabetes included in our analyses, 13 479 (0·5%) COVID-19-related deaths occurred during the study period (Feb 16 (...) Association between prescription of glucose-lowering drugs and COVID-19-related mortality Numbers of people are rounded to the nearest five to protect confidentiality. Rates of COVID-19 death in patients prescribed the specific drug are obtained by multiplying the hazard ratio by the rate in patients without the prescription of the drug. The size of the box is proportional to the inverse of the variance and the error bars show 95% CIs. n=number of events (deaths). N=total number of people. Figure 3

2021 EvidenceUpdates

18. Predictors of in-hospital mortality AND death RISK STRATIFICATION among COVID-19 PATIENTS aged >/= 80 YEARs OLD Full Text available with Trip Pro

Predictors of in-hospital mortality AND death RISK STRATIFICATION among COVID-19 PATIENTS aged >/= 80 YEARs OLD Predictors of in-hospital mortality AND death RISK STRATIFICATION among COVID-19 PATIENTS aged ≥ 80 YEARs OLD - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 Information Show account info Close Account Logged (...) Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation Arch Gerontol Geriatr Actions . 2021 Feb 25;95:104383. doi: 10.1016/j.archger.2021.104383. Online ahead of print. Predictors of in-hospital mortality AND death RISK STRATIFICATION among COVID-19 PATIENTS aged ≥ 80 YEARs OLD , , , , , , , , , , Affiliations Expand Affiliations 1 Emergency Department - Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Università Cattolica del Sacro Cuore

2021 EvidenceUpdates

19. National early warning score to predict intensive care unit transfer and mortality in COVID-19 in a French cohort Full Text available with Trip Pro

National early warning score to predict intensive care unit transfer and mortality in COVID-19 in a French cohort National early warning score to predict intensive care unit transfer and mortality in COVID-19 in a French cohort - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 Information Show account info Close Account (...) Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation Int J Clin Pract Actions . 2021 Mar 1;e14121. doi: 10.1111/ijcp.14121. Online ahead of print. National early warning score to predict intensive care unit transfer and mortality in COVID-19 in a French cohort , , , , , , , , , , , , , , , Affiliations Expand Affiliations 1 Internal Medicine Department, Univ. Lille, INSERM U1167, CHU Lille, Lille, France. 2 Infectious Disease Department, Univ

2021 EvidenceUpdates

20. Assessing the risk of maternal morbidity and mortality Full Text available with Trip Pro

Introduction The rates of maternal morbidity and mortality in the United States are unacceptably high. Centers for Disease Control and Prevention Rates in severe morbidity indicators per 10,000 delivery hospitalizations, 1993–2014 rates. Date: 2017 Date accessed: January 3, 2021 , Petersen E.E. Davis N.L. Goodman D. et al. Vital signs: pregnancy-related deaths, United States, 2011-2015, and strategies for prevention, 13 states, 2013-2017. MMWR Morb Mortal Wkly Rep. 2019; 68 : 423-429 Reducing the number (...) -related deaths: results of a state-wide review. Obstet Gynecol. 2005; 106 : 1228-1234 , Geller S.E. Koch A.R. Martin N.J. Rosenberg D. Bigger H.R. Illinois Department of Public Health Maternal Mortality Review Committee Working Group. Assessing preventability of maternal mortality in Illinois: 2002–2012. Am J Obstet Gynecol. 2014; 211 : 698.e1-698.e11 , Nelson D.B. Moniz M.H. Davis M.M. Population-level factors associated with maternal mortality in the United States, 1997–2012. BMC Public Health. 2018

2021 Society for Maternal-Fetal Medicine